MARK MCDADE - 10 Jun 2022 Form 4 Insider Report for Icosavax, Inc.

Role: Director
Signature: /s/ Mark McDade
Issuer symbol: N/A
Transactions as of: 10 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 14 Jun 2022, 16:12:30 UTC
Previous filing: 13 Jun 2022
Next filing: 08 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ICVX	Common Stock	Award	$0	+5,543	+11%	$0.000000	55,786	10 Jun 2022	Direct	F1
holding	ICVX	Common Stock						3,510,228	10 Jun 2022	By Qiming U.S. Healthcare Fund II, L.P.	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ICVX	Stock Option (Right to Buy)	Award	$0	+22,278		$0.000000	22,278	10 Jun 2022	Common Stock	22,278	$6.25	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent a restricted stock unit ("RSU") award, which shall vest at the earlier of (x) June 10, 2023 or (y) the date of the 2023 Annual Meeting of Stockholders. The vesting of the RSUs is subject to the Reporting Person's continuous service through such vesting date.
F2	The securities are directly held by Qiming U.S. Healthcare Fund II, L.P. ("Qiming"). Qiming U.S. Healthcare GP II, LLC ("Qiming GP") is the sole general partner of Qiming. The Reporting Person is a managing member of Qiming GP and may be deemed to share voting and dispositive power over the shares held by Qiming. The Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein.
F3	This option vests in substantially equal monthly installments over a twelve-month period commencing on July 10, 2022 (or, in the event the 2023 Annual Meeting of Stockholders occurs prior to June 10, 2023, any remaining unvested portion of the option will vest on the date of the 2023 Annual Meeting of Stockholders), subject to the Reporting Person's continuous service as of the applicable vesting date.